The importance of TP53 VAF was recently demonstrated in a study of 80 MDS patients (and 112 AML patients) who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) [58]. Here, TP53 is linked to acute myeloid leukemia.